Endovascular interventions in main renal artery pathologies: an overview and update

2021 ◽  
pp. 028418512110198
Author(s):  
Ansan Joseph ◽  
Jineesh Valakkada ◽  
Anoop Ayappan ◽  
Divyesh Dandhaniya
Keyword(s):  
Wide Spectrum ◽  
Renal Arteries ◽  
Management Options ◽  
Critical Determinant ◽  
Endovascular Interventions ◽  
Abdominal Aortic ◽  
Main Renal Artery ◽  
Long Term Prognosis ◽  
Transcatheter Interventions

Renal arteries are involved in a wide spectrum of pathologies including atherosclerosis, fibromuscular dysplasia, Takayasu arteritis, aneurysms, and aortic type B dissections extending into main renal arteries. They manifest as renovascular hypertension, renal ischemia, and cardiovascular dysfunction. The location of the renal arteries in relation to the abdominal aortic aneurysm is a critical determinant of interventional options and long-term prognosis. This article provides a comprehensive review of the role of interventional radiologists in transcatheter interventions in various pathologies involving the main renal arteries with analysis of epidemiology, pathophysiology, newer interventional techniques, and management options.

Back from the brink: a reversible cardiac cause of fetal hydrops

2020 ◽  
pp. 1-12
Author(s):  
David Lloyd ◽  
John Simpson ◽  
Vita Zedere
Keyword(s):  
Fetal Outcome ◽  
Fetal Hydrops ◽  
Management Options ◽  
Fetal Physiology ◽  
Wide Range ◽  
Term Delivery ◽  
Echocardiographic Assessment ◽  
Long Term Prognosis ◽  
Full Term Delivery

Fetal hydrops is a form of cardiovascular decompensation unique to fetal physiology, with a wide range of potential causes. In many conditions, it is associated with poor fetal outcome. This chapter explores a challenging case of fetal hydrops, discussing differential diagnoses, methods of echocardiographic assessment, and potential management options. Successful identification and treatment of the underlying cardiac disorder in this case led to complete resolution of hydrops, allowing for full-term delivery, with a good long-term prognosis.

scholarly journals IFT16. Long-term Outcomes of Visceral and Renal Arteries in Patients Treated With Branched/Fenestrated Endografts for Complex Abdominal Aortic Aneurysms

2019 ◽  
Vol 69 (6) ◽  
pp. e82-e83
Author(s):  
Laura Paperetti ◽  
Sara Speziali ◽  
Fabrizio Masciello ◽  
Aaron Fargion ◽  
Rossella Di Domenico ◽  
...  
Keyword(s):  
Abdominal Aortic Aneurysms ◽  
Renal Arteries ◽  
Aortic Aneurysms ◽  
Long Term Outcomes ◽  
Abdominal Aortic

Long-term Prognosis After Elective Abdominal Aortic Aneurysm Repair is Poor in Women and Men

2020 ◽  
Vol 272 (5) ◽  
pp. 773-778
Author(s):  
Ruth M. A. Bulder ◽  
Mareia Talvitie ◽  
Esther Bastiaannet ◽  
Jaap F. Hamming ◽  
Rebecka Hultgren ◽  
...  
Keyword(s):  
Abdominal Aortic Aneurysm ◽  
Aortic Aneurysm ◽  
Abdominal Aortic Aneurysm Repair ◽  
Abdominal Aortic ◽  
Long Term Prognosis ◽  
Aneurysm Repair ◽  
Aortic Aneurysm Repair ◽  
Elective Abdominal Aortic Aneurysm

Common neoplastic causes of paediatric and adolescent back pain

2020 ◽  
Vol 81 (5) ◽  
pp. 1-6
Author(s):  
Jasmine Brown ◽  
Sandesh Lakkol ◽  
Sophia Lazenby ◽  
Mark Harris
Keyword(s):  
Back Pain ◽  
Clinical Practice ◽  
Spinal Column ◽  
Red Flags ◽  
Malignant Tumours ◽  
Spinal Neoplasms ◽  
Management Options ◽  
Successful Clinical Outcome ◽  
Long Term Prognosis

Neoplasm of the spinal column in children is rare, but can involve either benign or malignant tumours. Early detection of malignant tumours is key to successful clinical outcome and long-term prognosis. In such cases, back pain is a common presenting symptom, but often has a non-neoplastic cause. Therefore, it is important for GPs and trainees who encounter paediatric patients to be aware of the clinical entity to be able to thoroughly assess them in clinical practice. This article discusses the types of paediatric spinal neoplasms, anatomical-based classification, clinical red flags, imaging modalities and outlines brief management options.

scholarly journals Caucasian lean subjects with non-alcoholic fatty liver disease share long-term prognosis of non-lean: time for reappraisal of BMI-driven approach?

Gut ◽  
2021 ◽  
pp. gutjnl-2020-322564 ◽  
Author(s):  
Ramy Younes ◽  
Olivier Govaere ◽  
Salvatore Petta ◽  
Luca Miele ◽  
Dina Tiniakos ◽  
...  
Keyword(s):  
Liver Disease ◽  
Fatty Liver Disease ◽  
Wide Spectrum ◽  
Phenotypic Expression ◽  
Alcoholic Fatty Liver ◽  
Long Term Prognosis ◽  
Metabolic Comorbidities ◽  
Alcoholic Fatty Liver Disease

ObjectiveThe full phenotypic expression of non-alcoholic fatty liver disease (NAFLD) in lean subjects is incompletely characterised. We aimed to investigate prevalence, characteristics and long-term prognosis of Caucasian lean subjects with NAFLD.DesignThe study cohort comprises 1339 biopsy-proven NAFLD subjects from four countries (Italy, UK, Spain and Australia), stratified into lean and non-lean (body mass index (BMI) </≥25 kg/m2). Liver/non-liver-related events and survival free of transplantation were recorded during the follow-up, compared by log-rank testing and reported by adjusted HR.ResultsLean patients represented 14.4% of the cohort and were predominantly of Italian origin (89%). They had less severe histological disease (lean vs non-lean: non-alcoholic steatohepatitis 54.1% vs 71.2% p<0.001; advanced fibrosis 10.1% vs 25.2% p<0.001), lower prevalence of diabetes (9.2% vs 31.4%, p<0.001), but no significant differences in the prevalence of the PNPLA3 I148M variant (p=0.57). During a median follow-up of 94 months (>10 483 person-years), 4.7% of lean vs 7.7% of non-lean patients reported liver-related events (p=0.37). No difference in survival was observed compared with non-lean NAFLD (p=0.069).ConclusionsCaucasian lean subjects with NAFLD may progress to advanced liver disease, develop metabolic comorbidities and experience cardiovascular disease (CVD) as well as liver-related mortality, independent of longitudinal progression to obesity and PNPLA3 genotype. These patients represent one end of a wide spectrum of phenotypic expression of NAFLD where the disease manifests at lower overall BMI thresholds.Lay summaryNAFLD may affect and progress in both obese and lean individuals. Lean subjects are predominantly males, have a younger age at diagnosis and are more prevalent in some geographic areas. During the follow-up, lean subjects can develop hepatic and extrahepatic disease, including metabolic comorbidities, in the absence of weight gain. These patients represent one end of a wide spectrum of phenotypic expression of NAFLD.

Sign in / Sign up

Export Citation Format

Share Document